FindTrial
Sign In

Midazolam, dexmedetomidine or ketamine: which of these used intranasally as premedication has better outcomes in childer undergoing brain MRI

Comparision between intranasal dexmedetomidine, midazolam and ketamine as premedication for paediatric patients undergoing brain MRI: a prospective randomised double blind study - MRI- MAGNETIC RESONANCE IMAGING

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/11/016366
Enrollment
120
Registered
2018-11-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G80-G83- Cerebral palsy and other paralytic syndromes

Interventions

Control Intervention1: ketamine 3mg/kg body weight: group K received 3 mg/kg of ketamine intranasally 15 minutes prior to undergoing brain MRI Control Intervention2: dexmedetomidine 1microgram/kg body

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA-PS 1 &2

Exclusion criteria

Exclusion criteria: patients below 1 year of age patients above 6 years of age parents refusal to participate in the study ASA-PS 3 and above any congenital heart disease on beta blocker or digoxin therapy any implants incompatible with MRI patient requiring emergency MRI

Design outcomes

Primary

MeasureTime frame
TO COMPARE THE EFFECT OF INTRANASAL DEXMEDITOMIDINE, MIDAZOLAM AND KETAMINE IN PARENT-CHILD SEPARATION SCORETimepoint: 30 minutes—

Secondary

MeasureTime frame
1. TO COMPARE THE EFFECT OF INTRANASAL DEXMEDITOMIDINE, MIDAZOLAM, KETAMINE IN SEDATION OF THE CHILD BY OBSERVER ASSESSMENT SCORE. 2. TO LOOK FOR ANY SIDE EFFECTS OF THE STUDY DRUG.Timepoint: 6 hours—

Countries

India

Contacts

Public ContactDR UD SHARMA

DR. S.N. MEDICAL COLLEGE

drpayaljain30@gmail.com9085764394

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026